The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $183.98 million. The enterprise value is $380.63 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SKIN has 126.01 million shares outstanding. The number of shares has decreased by -3.90% in one year.
Current Share Class | 126.01M |
Shares Outstanding | 126.01M |
Shares Change (YoY) | -3.90% |
Shares Change (QoQ) | +0.54% |
Owned by Insiders (%) | 9.87% |
Owned by Institutions (%) | 57.42% |
Float | 80.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.56 |
Forward PS | 0.62 |
PB Ratio | 3.97 |
P/TBV Ratio | n/a |
P/FCF Ratio | 5.18 |
P/OCF Ratio | 5.11 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.18 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 10.71 |
Financial Position
The company has a current ratio of 7.47, with a Debt / Equity ratio of 12.32.
Current Ratio | 7.47 |
Quick Ratio | 6.28 |
Debt / Equity | 12.32 |
Debt / EBITDA | n/a |
Debt / FCF | 15.98 |
Interest Coverage | -6.36 |
Financial Efficiency
Return on equity (ROE) is -70.44% and return on invested capital (ROIC) is -5.77%.
Return on Equity (ROE) | -70.44% |
Return on Assets (ROA) | -5.17% |
Return on Invested Capital (ROIC) | -5.77% |
Return on Capital Employed (ROCE) | -10.28% |
Revenue Per Employee | $419,338 |
Profits Per Employee | -$50,085 |
Employee Count | 769 |
Asset Turnover | 0.42 |
Inventory Turnover | 1.73 |
Taxes
In the past 12 months, SKIN has paid $1.10 million in taxes.
Income Tax | 1.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.78% in the last 52 weeks. The beta is 1.17, so SKIN's price volatility has been higher than the market average.
Beta (5Y) | 1.17 |
52-Week Price Change | -19.78% |
50-Day Moving Average | 1.36 |
200-Day Moving Average | 1.49 |
Relative Strength Index (RSI) | 44.98 |
Average Volume (20 Days) | 595,319 |
Short Selling Information
The latest short interest is 8.37 million, so 6.64% of the outstanding shares have been sold short.
Short Interest | 8.37M |
Short Previous Month | 8.05M |
Short % of Shares Out | 6.64% |
Short % of Float | 10.44% |
Short Ratio (days to cover) | 7.38 |
Income Statement
In the last 12 months, SKIN had revenue of $322.47 million and -$38.52 million in losses. Loss per share was -$0.39.
Revenue | 322.47M |
Gross Profit | 182.52M |
Operating Income | -62.81M |
Pretax Income | -80.63M |
Net Income | -38.52M |
EBITDA | -31.61M |
EBIT | -62.81M |
Loss Per Share | -$0.39 |
Full Income Statement Balance Sheet
The company has $371.03 million in cash and $567.69 million in debt, giving a net cash position of -$196.66 million or -$1.56 per share.
Cash & Cash Equivalents | 371.03M |
Total Debt | 567.69M |
Net Cash | -196.66M |
Net Cash Per Share | -$1.56 |
Equity (Book Value) | 46.06M |
Book Value Per Share | 0.37 |
Working Capital | 406.57M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $35.98 million and capital expenditures -$457,000, giving a free cash flow of $35.53 million.
Operating Cash Flow | 35.98M |
Capital Expenditures | -457,000 |
Free Cash Flow | 35.53M |
FCF Per Share | $0.28 |
Full Cash Flow Statement Margins
Gross margin is 56.60%, with operating and profit margins of -19.48% and -11.94%.
Gross Margin | 56.60% |
Operating Margin | -19.48% |
Pretax Margin | -11.60% |
Profit Margin | -11.94% |
EBITDA Margin | -9.80% |
EBIT Margin | -19.48% |
FCF Margin | 11.02% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 3.90% |
Shareholder Yield | 3.90% |
Earnings Yield | -20.93% |
FCF Yield | 19.31% |
Analyst Forecast
The average price target for SKIN is $1.42, which is -2.74% lower than the current price. The consensus rating is "Hold".
Price Target | $1.42 |
Price Target Difference | -2.74% |
Analyst Consensus | Hold |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.04 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.04 |
Piotroski F-Score | 5 |